Literature DB >> 25903731

Amyloid beta-42 (Aβ-42), neprilysin and cytokine levels. A pilot study in patients with HIV related cognitive impairments.

K M Mothapo1, F Stelma2, M Janssen3, R Kessels3, S Miners4, M M Verbeek5, P Koopmans6, A van der Ven6.   

Abstract

HIV-associated dementia (HAD) is associated with amyloid-beta (Aβ) deposition. This study measured CSF and plasma amyloid beta-42 (Aβ-42), neprilysin (NEP) and cytokine levels in HIV-related cognitive impairments (HCI), HIV normal cognitive functioning (NF) and non-HIV controls. Our data showed a trend towards detectable plasma Aβ-42 levels more frequently in HCI (67%), when compared to NF (29%) and controls (10%). We showed elevated IL-8 levels in CSF of HCI compared to NF, although not significant values. The data from this pilot study indicates that CSF IL-8 and plasma Aβ-42 may be interesting biomarkers for the presence of HCI.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Amyloid beta-42; Anti-inflammatory cytokines; HIV associated neurocognitive disorders; HIV related cognitive impairments; Neprilysin; Pro-inflammatory cytokines

Mesh:

Substances:

Year:  2015        PMID: 25903731     DOI: 10.1016/j.jneuroim.2015.03.017

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

Review 1.  HIV/neuroAIDS biomarkers.

Authors:  Pejman Rahimian; Johnny J He
Journal:  Prog Neurobiol       Date:  2016-04-12       Impact factor: 11.685

2.  Soluble TLR2 and 4 concentrations in cerebrospinal fluid in HIV/SIV-related neuropathological conditions.

Authors:  Khutso M Mothapo; J Ten Oever; P Koopmans; F F Stelma; S Burm; J Bajramovic; M M Verbeek; M G Olde Rikkert; M G Netea; G Koopman; A J van der Ven
Journal:  J Neurovirol       Date:  2016-11-23       Impact factor: 2.643

3.  Biomarkers of neuronal injury and amyloid metabolism in the cerebrospinal fluid of patients infected with HIV-1 subtypes B and C.

Authors:  Sérgio Monteiro de Almeida; Clea E Ribeiro; Indianara Rotta; Mauro Piovesan; Bin Tang; Florin Vaida; Sonia Mara Raboni; Scott Letendre; Michael Potter; Meire S Batistela Fernandes; Ronald J Ellis
Journal:  J Neurovirol       Date:  2017-10-23       Impact factor: 2.643

4.  Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients.

Authors:  A Calcagno; C Atzori; A Romito; D Vai; S Audagnotto; M L Stella; C Montrucchio; D Imperiale; G Di Perri; S Bonora
Journal:  J Neurovirol       Date:  2015-08-06       Impact factor: 2.643

5.  Linked CSF reduction of phosphorylated tau and IL-8 in HIV associated neurocognitive disorder.

Authors:  Tugba Ozturk; Alexander Kollhoff; Albert M Anderson; J Christina Howell; David W Loring; Drenna Waldrop-Valverde; Donald Franklin; Scott Letendre; William R Tyor; William T Hu
Journal:  Sci Rep       Date:  2019-06-19       Impact factor: 4.379

Review 6.  Neprilysin expression and functions in development, ageing and disease.

Authors:  N N Nalivaeva; I A Zhuravin; A J Turner
Journal:  Mech Ageing Dev       Date:  2020-09-26       Impact factor: 5.432

7.  CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice.

Authors:  Biju Bhargavan; Shawna M Woollard; Jo Ellyn McMillan; Georgette D Kanmogne
Journal:  Mol Neurodegener       Date:  2021-11-22       Impact factor: 14.195

8.  Abundance of Nef and p-Tau217 in Brains of Individuals Diagnosed with HIV-Associated Neurocognitive Disorders Correlate with Disease Severance.

Authors:  Tatiana Pushkarsky; Adam Ward; Andrey Ivanov; Xionghao Lin; Dmitri Sviridov; Sergei Nekhai; Michael I Bukrinsky
Journal:  Mol Neurobiol       Date:  2021-11-29       Impact factor: 5.590

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.